Rare diseases
Investigational molecules
Locations
Study of Camizestrant plus Ribociclib as First‑Line Treatment for Patients with ER‑Positive, HER2‑Negative Advanced Breast Cancer
PolandJNJ-95597528 for Adults with Moderate to Severe Atopic Dermatitis
PolandBaricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
PolandPhase 3 Study of INCB123667 versus investigator's choice of chemotherapy drug combination in patients with platinum‑resistant ovarian cancer and cyclin E1 overexpression
PolandStudy of tarlatamab and durvalumab compared to durvalumab alone for patients with extensive stage small cell lung cancer
PolandA Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa
PolandPhase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis
PolandA study evaluating glofitamab and a drug combination for patients with relapsed or refractory diffuse large B-cell lymphoma.
PolandEvaluation of Pembrolizumab, Patritumab Deruxtecan, and Drug Combinations in Stage IV Non-Small Cell Lung Cancer: A Phase 2 Umbrella Study
PolandEfficacy and Safety Evaluation of Belantamab Mafodotin Versus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
PolandA study testing ALN-4324 for safety and effectiveness in overweight to obese patients with type 2 diabetes
PolandStudy of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
